The MoH recently announced a transition to Publicly Funded Shingrix® Vaccine for Ontario’s Shingles (Herpes Zoster) Immunization Program. Note, this is for patients between 65-70 years of age. Here is more information: OPDP SHINGRIX funded Oct 2020
Other Articles in the Fall 2020 Newsletter
Contributors
The ORA’s executive members are the core contributors to the newsletter. The ORA welcomes guest contributions to the newsletter from members-at-large and others in the rheumatology community.
